Luisa Fioretto

2.5k total citations · 1 hit paper
31 papers, 1.3k citations indexed

About

Luisa Fioretto is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Luisa Fioretto has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Economics and Econometrics. Recurrent topics in Luisa Fioretto's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (7 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Luisa Fioretto is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (7 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Luisa Fioretto collaborates with scholars based in Italy, Netherlands and United States. Luisa Fioretto's co-authors include Alfredo Falcone, Cristina Granetto, Lucio Crinò, M. Andreuccetti, Gianluca Masi, V. Picone, E. Pfanner, Giovanni Benedetti, C. Barbara and Cinzia Orlandini and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and The Lancet Oncology.

In The Last Decade

Luisa Fioretto

30 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest

2007 872 citations Alfredo Falcone, Sergio Ricci et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luisa Fioretto Italy	12	1.1k	517	414	303	110	31	1.3k
Geert-Jan Creemers Netherlands	15	907 0.8×	250 0.5×	376 0.9×	489 1.6×	191 1.7×	44	1.4k
Andrew McKay Canada	19	617 0.6×	249 0.5×	418 1.0×	584 1.9×	73 0.7×	43	1.2k
Beodeul Kang South Korea	21	756 0.7×	344 0.7×	373 0.9×	322 1.1×	192 1.7×	99	1.4k
Hélène Senellart France	19	862 0.8×	130 0.3×	379 0.9×	293 1.0×	113 1.0×	78	1.2k
Aliki Taylor United Kingdom	18	613 0.6×	320 0.6×	340 0.8×	322 1.1×	70 0.6×	50	1.7k
Jeffrey P. Meyers United States	17	863 0.8×	207 0.4×	408 1.0×	528 1.7×	317 2.9×	40	1.4k
Christian Sebesta Austria	13	562 0.5×	204 0.4×	224 0.5×	240 0.8×	113 1.0×	47	845
Manuel Gallén Spain	17	1.0k 0.9×	235 0.5×	380 0.9×	502 1.7×	220 2.0×	33	1.5k
Suzanne Kosmider Australia	16	699 0.6×	122 0.2×	253 0.6×	167 0.6×	255 2.3×	87	909
Anne M. Horgan Ireland	16	741 0.7×	96 0.2×	795 1.9×	900 3.0×	95 0.9×	76	1.4k

Countries citing papers authored by Luisa Fioretto

Since Specialization

Citations

This map shows the geographic impact of Luisa Fioretto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Fioretto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Fioretto more than expected).

Fields of papers citing papers by Luisa Fioretto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa Fioretto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Fioretto. The network helps show where Luisa Fioretto may publish in the future.

Co-authorship network of co-authors of Luisa Fioretto

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa Fioretto. A scholar is included among the top collaborators of Luisa Fioretto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa Fioretto. Luisa Fioretto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Altini, Mattia, Gianni Amunni, Ovidio Brignoli, et al.. (2025). Real World Evidence in Oncology: An Italian examples-based Expert Opinion on Advancing Clinical and Regulatory Decision-Making. 5(1). 7–7. 1 indexed citations

Ascierto, Paolo A., Pietro Quaglino, Francesco Spagnolo, et al.. (2024). Combination or sequence of vemurafenib, cobimetinib, and atezolizumab in high-risk, resectable melanoma (NEO-TIM): Primary results.. Journal of Clinical Oncology. 42(17_suppl). LBA9513–LBA9513. 2 indexed citations

Ascierto, Paolo A., Vanna Chiarion‐Sileni, Pietro Quaglino, et al.. (2023). Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study. Frontiers in Oncology. 13. 1107307–1107307. 2 indexed citations

Cheli, Simone, et al.. (2022). The Relationship Between Covid-19 Risk Perception and Vaccine Hesitancy in Cancer Patients: The Moderating Role of Externalizing Traits.. PubMed. 19(6). 355–364. 2 indexed citations

Bacci, Giovanni, et al.. (2021). Melanoma diagnosis: traumatic impact of the event on the patient. Italian Journal of Dermatology and Venereology. 156(3).

Paoli, Camilla Delli, L. Paoletti, Saverio Caini, et al.. (2021). Acute tolerance of Moderna mRNA-1273 vaccine against COVID-19 in patients with cancer treated with radiotherapy. The Lancet Oncology. 22(9). 1212–1214. 6 indexed citations

Cheli, Simone, Wwt Lam, Tania Estapé, et al.. (2021). Risk perception, treatment adherence, and personality during COVID‐19 pandemic: An international study on cancer patients. Psycho-Oncology. 31(1). 46–53. 14 indexed citations

Indini, Alice, C. Aschele, Luigi Cavanna, et al.. (2020). Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey. European Journal of Cancer. 132. 17–23. 73 indexed citations

DeCensi, Andrea, Gianmauro Numico, Enzo Ballatori, et al.. (2018). Conflict of interest among Italian medical oncologists: a national survey. BMJ Open. 8(6). e020912–e020912. 5 indexed citations

10.

Montagnani, Francesca, Lorenzo Fornaro, Paolo Frumento, et al.. (2017). Multimodality treatment of locally advanced squamous cell carcinoma of the oesophagus: A comprehensive review and network meta-analysis. Critical Reviews in Oncology/Hematology. 114. 24–32. 25 indexed citations

11.

Pino, Maria Simona, et al.. (2015). A preliminary validation of an Italian version of the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF-I). Annals of Oncology. 26. vi116–vi116. 1 indexed citations

12.

Martella, Francesca, Vanda Salutari, Cláudia Marchetti, et al.. (2015). A retrospective analysis of trabectedin infusion by peripherally inserted central venous catheters. Anti-Cancer Drugs. 26(9). 990–994. 16 indexed citations

13.

Martella, Francesca, et al.. (2015). Eribulin mesylate in advanced breast cancer: retrospective review of a single institute experience. Future Oncology. 11(sup15). 31–36. 18 indexed citations

14.

Pino, Maria Simona, et al.. (2014). A Simultaneous Approach to Care: an Italian Tertiary Cancer Center Experience. Annals of Oncology. 25. iv474–iv474. 1 indexed citations

15.

Pino, Maria Simona, Catia Angiolini, & Luisa Fioretto. (2013). Severe thrombocytopenia after trastuzumab retreatment: a case report. BMC Research Notes. 6(1). 400–400. 10 indexed citations

16.

Ribecco, Angela Stefania, et al.. (2013). Molecularly targeted therapy: toxicity and quality of life considerations in advanced colorectal cancer. Expert Review of Anticancer Therapy. 13(10). 1181–1191. 7 indexed citations

17.

Masi, Gianluca, Fotios Loupakis, Lorenzo Fornaro, et al.. (2010). Randomized Trial of Two Induction Chemotherapy Regimens in Metastatic Colorectal Cancer: An Updated Analysis. JNCI Journal of the National Cancer Institute. 103(1). 21–30. 137 indexed citations

18.

Falcone, Alfredo, Sergio Ricci, I. Brunetti, et al.. (2007). Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest. Journal of Clinical Oncology. 25(13). 1670–1676. 872 indexed citations breakdown →

19.

Neri, B, Laura Doni, Mauro Turrini, et al.. (2002). Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: a multicenter phase II study. British Journal of Cancer. 87(5). 497–501. 20 indexed citations

20.

Tibaldi, Carmelo, et al.. (1998). Epirubicin/vinorelbine as first line therapy in metastatic breast cancer. Breast Cancer Research and Treatment. 49(2). 129–134. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact